License Agreement and Clinical Research Organization - Additional Information (Details) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | |||
|---|---|---|---|---|---|
Apr. 10, 2020 |
Jul. 31, 2026 |
Jul. 31, 2025 |
Jul. 31, 2026 |
Jul. 31, 2025 |
|
| License Agreement and Clinical Research Organization [Line Items] | |||||
| Annual maintenance fee | $ 50 | ||||
| Payment to NTC upon assigning the License Agreement | 50 | ||||
| Phase I Clinical Trial [Member] | |||||
| License Agreement and Clinical Research Organization [Line Items] | |||||
| One-time payment for milestone product | 50 | ||||
| Phase II Clinical Trial [Member] | |||||
| License Agreement and Clinical Research Organization [Line Items] | |||||
| One-time payment for milestone product | 450 | ||||
| Location, Statement of Income, Balance [Axis]: us-gaap:ResearchAndDevelopmentExpense | |||||
| License Agreement and Clinical Research Organization [Line Items] | |||||
| Upfront fee | $ 50 | ||||
| Fee related to the manufacturing payment | $ 0 | ||||
| Expenses related to the annual maintenance fee | $ 13 | $ 13 | $ 38 | $ 38 | |